Drug Information

Drug General Information
Drug ID
D0TV6H
Former ID
DIB006781
Drug Name
HuM-195-Ac-225
Synonyms
HuM-195 [225Ac]; SMART 225Ac-M195; Actinium-225-M195; SMART actinium-225-M195; Actinium-225-HuM-195; 225Ac-HuM-195; 225Ac-lintuzumab
Indication Acute myeloid leukemia [ICD9: 205; ICD10:C92.0] Phase 1/2 [550199]
Company
PDL BioPharma Inc
Target and Pathway
Target(s) Myeloid cell surface antigen CD33 Target Info Inhibitor [549712]
KEGG Pathway Hematopoietic cell lineage
Reactome Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
References
Ref 550199Clinical pipeline report, company report or official report of Actinium Pharmaceuticals.
Ref 549712J Clin Oncol 29: 2011 (suppl; abstr 6516).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.